NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹2,194 Cr | ₹1,751 Cr | ₹912 Cr | ₹264 Cr | ₹604 Cr |
What is the latest Operating Profit of NATCO PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹2,194 Cr |
| Mar2024 | ₹1,751 Cr |
| Mar2023 | ₹912 Cr |
| Mar2022 | ₹264 Cr |
| Mar2021 | ₹604 Cr |
How is Operating Profit of NATCO PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,194 Cr | 25.26 | |
| Mar2024 | ₹1,751 Cr | 92.10 | |
| Mar2023 | ₹912 Cr | 246.00 | |
| Mar2022 | ₹264 Cr | -56.36 | |
| Mar2021 | ₹604 Cr | - | |
Compare Operating Profit of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹19,551.5 Cr | -1.8% | 7.5% | 40.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -1% | -7% | -1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 5% | -2.7% | 15.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -6.2% | 29.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 2.3% | -8.1% | 13.5% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.9% | -7.8% | -12.5% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -1.8% |
7.5% |
40.5% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses